Overview
Michael F. Buchanan is a litigation partner focusing his practice on patent litigation and white collar defense and investigations. A skilled trial lawyer, Mr. Buchanan has served as one of the lead attorneys in several complex federal patent trials on behalf of major pharmaceutical companies. He has tried several complex civil and criminal cases to verdict and argued multiple appeals. His white collar representations have involved allegations of securities fraud, insider trading, tax fraud, accounting fraud, health care and medicare fraud, and theft of trade secrets.
Previously, Mr. Buchanan spent over nine years at the U.S. Attorney’s Office for the District of New Jersey, where he served as Chief of the Securities and Health Care Fraud Unit, focusing on the investigation and prosecution of criminal violations of the federal securities and health care fraud statutes. These matters involved insider trading, FCPA health care kickbacks, off-label marketing and Medicare/Medicaid and private insurance fraud. He was involved in some of the office's most significant and high-profile securities and health care fraud prosecutions. Mr. Buchanan also served as the Deputy Chief of the District’s Criminal Division and as the Chief of its Terrorism Unit.
Prior to practicing law, Mr. Buchanan was a structural engineer at Grumman Aerospace. He served as a law clerk at a boutique intellectual property law firm where he participated in all aspects of the firm's patent litigation and prosecution practice. Mr. Buchanan is a member of the patent bar and a registered patent agent. He served as a Law Clerk to the Hon. Franklin S. Van Antwerpen, U.S. District Court for the Eastern District of Pennsylvania and then spent several years in private practice in one of New York City's top boutique white collar criminal defense law firms before becoming a federal prosecutor.
Mr. Buchanan has spoken before various professional organizations on topics including criminal investigations in securities fraud, as well as the Foreign Intelligence Surveillance Act.